Agilent Technologies Introduces Human Copy Number Variation Microarrays Based on WTCCC Design Used In World's Largest Study

Agilent Technologies, Inc. (NYSE: A) today introduced the Human CNV Association 2x105K microarray for studying associations between genomic copy number variations (CNV) and disease. The array is based on a design by the Wellcome Trust Case Control Consortium (WTCCC), which is conducting the world’s largest study of CNVs and their relationships to a number of widespread disorders.

Source: Agilent Technologies